CLINICAL TRIAL TO EVALUATE THE EFFICACY OF JALA BASTI IN PROPHYLAXIS OF PREDIABETES
Dr. Praveen Singh*, Prof. Satya Manav Dayal, Dr. Mannat Marwaha
ABSTRACT
Pre-diabetes/ intermediate hyperglycaemia grounded on glycaemic variables above normal range but under diabetes thresholds. The prevalence of pre-diabetes is surging all over the world and it is estimated that >470 million people will develop pre-diabetes in 2030. Lifestyle modification is the mainspring of diabetes prevention with documentation of a 40%–70% relative risk reduction. So, open clinical trial on an Ayurvedic intervention Jala basti was planned in prophylaxis of Pre-diabetes. Aim of the trial was to evaluate the effect of Jala Basti in prophylaxis of Pre-diabetes. 40 Pre diabetic Patients who were willing for trial, aged between 20-70 years of either sex, having Hemoglobin A1C range between 5.7% to 6.4%, FBG (fasting blood glucose) range 100 mg/dl to 125 mg/dl, OGTT (Oral glucose tolerance test 2 hour blood glucose) range between 140 mg/dl to 199 mg/dl, RBS (random blood sugar level) greater than or equal to 200 mg/dl were selected from OPD and IPD of Dept. Of Swasthwrita, Hospital of Uttaranchal Ayurvedic Collage, Uttarakhand Ayurved University, Dehradun. Patients below age of 20 years and above 70 years of age, all type 1 and type 2 Diabetes mellitus cases and cases with complications of the disease or having other associated disease were excluded from trial. The assessment of relief in Blood sugar fasting, RBS, OGTT, HBA1C has been shown as 12.24%, 16.27%, 14.36% and 3.8% relief respectively. The p value for all these is
[Full Text Article] [Download Certificate]